Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2013 Sep 19;33(11):2674–2681. doi: 10.1161/ATVBAHA.113.302137

Table 4.

Frequency of the A3 Haplotype in PROCR

Non-A3 Genotype A3 Heterozygotes A3 Homozygotes Total A3 Haplotype
ELATE patients (n=657) 497 (77.1%) 137 (21.2%) 11 (1.7%) 148 (22.9%)*
Controls (n=627) 501 (86.5%) 72 (12.4%) 6 (1.0%) 80 (13.5%)
*

P=<0.001 for ELATE patients compared to all controls